Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B.

J Biol Chem 2005 Apr 8;280(16):15809-14. Epub 2005 Mar 8.

Department of Public Health and Cell Biology, University of Rome "Tor Vergata," 00173 Rome, Italy.

Myeloid differentiation factor 88 (MyD88) plays a crucial role in the signaling pathways triggered by interleukin (IL)-1 and Toll-like receptors in several steps of innate host defense. A crucial event in this signaling pathway is represented by dimerization of MyD88, which allows the recruitment of downstream kinases like IRAK-1 and IRAK-4. Herein, we have investigated the function of the Toll/IL-1 receptor (TIR) domain in MyD88 homodimerization in cell-free and in vitro experimental settings by using epta-peptides that mimic the BB-loop region of the conserved TIR domain of different proteins. By using a pull-down assay with purified glutathione S-transferase-MyD88 TIR or co-immunoprecipitation experiments, we found that epta-peptides derived from the TIR domain of MyD88 and IL-18R are the most effective in inhibiting homodimerization with either the isolated TIR or full-length MyD88. Moreover, we demonstrated that a cell permeable analog of MyD88 epta-peptide inhibits homodimerization of MyD88 TIR domains in an in vitro cell system and significantly reduces IL-1 signaling, as assayed by activation of the downstream transcription factor NF-kappaB. Our results indicate that the BB-loop in TIR domain of MyD88 is a good target for specific inhibition of MyD88-mediated signaling in vivo.

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.C400613200DOI Listing
April 2005
20 Reads

Publication Analysis

Top Keywords

tir domain
20
domain myd88
12
myd88
9
dimerization myd88
8
tir
8
domain
5
investigated function
4
function toll/il-1
4
irak-4 investigated
4
cell permeable
4
myd88 demonstrated
4
demonstrated cell
4
receptor tir
4
myd88 homodimerization
4
homodimerization cell-free
4
irak-1 irak-4
4
full-length myd88
4
toll/il-1 receptor
4
downstream kinases
4
myd88 allows
4

Altmetric Statistics

Similar Publications